Marina Bakay1, Rahul Pandey1, Struan F A Grant1,2,3,4, Hakon Hakonarson5,6. 1. The Center for Applied Genomics, Division of Human Genetics, The Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Abramson Research Center, Suite 1216B, Philadelphia, PA, 19104-4318, USA. 2. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 3. Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 4. Center for Spatial and Functional Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. 5. The Center for Applied Genomics, Division of Human Genetics, The Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Abramson Research Center, Suite 1216B, Philadelphia, PA, 19104-4318, USA. hakonarson@email.chop.edu. 6. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. hakonarson@email.chop.edu.
Abstract
PURPOSE OF REVIEW: To provide an updated summary of discoveries made to date resulting from genome-wide association study (GWAS) and sequencing studies, and to discuss the latest loci added to the growing repertoire of genetic signals predisposing to type 1 diabetes (T1D). RECENT FINDINGS: Genetic studies have identified over 60 loci associated with T1D susceptibility. GWAS alone does not specifically inform on underlying mechanisms, but in combination with other sequencing and omics-data, advances are being made in our understanding of T1D genetic etiology and pathogenesis. Current knowledge indicates that genetic variation operating in both pancreatic β cells and in immune cells is central in mediating T1D risk. One of the main challenges is to determine how these recently discovered GWAS-implicated variants affect the expression and function of gene products. Once we understand the mechanism of action for disease-causing variants, we will be well placed to apply targeted genomic approaches to impede the premature activation of the immune system in an effort to ultimately prevent the onset of T1D.
PURPOSE OF REVIEW: To provide an updated summary of discoveries made to date resulting from genome-wide association study (GWAS) and sequencing studies, and to discuss the latest loci added to the growing repertoire of genetic signals predisposing to type 1 diabetes (T1D). RECENT FINDINGS: Genetic studies have identified over 60 loci associated with T1D susceptibility. GWAS alone does not specifically inform on underlying mechanisms, but in combination with other sequencing and omics-data, advances are being made in our understanding of T1D genetic etiology and pathogenesis. Current knowledge indicates that genetic variation operating in both pancreatic β cells and in immune cells is central in mediating T1D risk. One of the main challenges is to determine how these recently discovered GWAS-implicated variants affect the expression and function of gene products. Once we understand the mechanism of action for disease-causing variants, we will be well placed to apply targeted genomic approaches to impede the premature activation of the immune system in an effort to ultimately prevent the onset of T1D.
Entities:
Keywords:
Autoimmunity; C-type lectin-like domain family 16A (CLEC16A) gene; Genome-wide association study (GWAS); Susceptibility loci; Type 1 diabetes (T1D)
Authors: M V Prasad Linga Reddy; H Wang; S Liu; B Bode; J C Reed; R D Steed; S W Anderson; L Steed; D Hopkins; J-X She Journal: Genes Immun Date: 2011-01-27 Impact factor: 2.676
Authors: Scott A Soleimanpour; Aditi Gupta; Marina Bakay; Alana M Ferrari; David N Groff; João Fadista; Lynn A Spruce; Jake A Kushner; Leif Groop; Steven H Seeholzer; Brett A Kaufman; Hakon Hakonarson; Doris A Stoffers Journal: Cell Date: 2014-06-19 Impact factor: 41.582
Authors: Winfred W Williams; Rany M Salem; Amy Jayne McKnight; Niina Sandholm; Carol Forsblom; Andrew Taylor; Candace Guiducci; Jarred B McAteer; Gareth J McKay; Tamara Isakova; Eoin P Brennan; Denise M Sadlier; Cameron Palmer; Jenny Söderlund; Emma Fagerholm; Valma Harjutsalo; Raija Lithovius; Daniel Gordin; Kustaa Hietala; Janne Kytö; Maija Parkkonen; Milla Rosengård-Bärlund; Lena Thorn; Anna Syreeni; Nina Tolonen; Markku Saraheimo; Johan Wadén; Janne Pitkäniemi; Cinzia Sarti; Jaakko Tuomilehto; Karl Tryggvason; Anne-May Österholm; Bing He; Steve Bain; Finian Martin; Catherine Godson; Joel N Hirschhorn; Alexander P Maxwell; Per-Henrik Groop; Jose C Florez Journal: Diabetes Date: 2012-06-20 Impact factor: 9.461
Authors: Lucy J Davison; Chris Wallace; Jason D Cooper; Nathan F Cope; Nicola K Wilson; Deborah J Smyth; Joanna M M Howson; Nada Saleh; Abdullah Al-Jeffery; Karen L Angus; Helen E Stevens; Sarah Nutland; Simon Duley; Richard M R Coulson; Neil M Walker; Oliver S Burren; Catherine M Rice; Francois Cambien; Tanja Zeller; Thomas Munzel; Karl Lackner; Stefan Blakenberg; Peter Fraser; Berthold Gottgens; John A Todd; Tony Attwood; Stephanie Belz; Peter Braund; François Cambien; Jason Cooper; Abi Crisp-Hihn; Patrick Diemert; Panos Deloukas; Nicola Foad; Jeanette Erdmann; Alison H Goodall; Jay Gracey; Emma Gray; Rhian G Williams; Susanne Heimerl; Christian Hengstenberg; Jennifer Jolley; Unni Krishnan; Heather Lloyd-Jones; Ingrid Lugauer; Per Lundmark; Seraya Maouche; Jasbir S Moore; David Muir; Elizabeth Murray; Chris P Nelson; Jessica Neudert; David Niblett; Karen O'Leary; Willem H Ouwehand; Helen Pollard; Angela Rankin; Catherine M Rice; Hendrik Sager; Nilesh J Samani; Jennifer Sambrook; Gerd Schmitz; Michael Scholz; Laura Schroeder; Heribert Schunkert; Ann-Christine Syvannen; Stefanie Tennstedt; Chris Wallace Journal: Hum Mol Genet Date: 2011-10-11 Impact factor: 6.150
Authors: Chris Wallace; Deborah J Smyth; Meeta Maisuria-Armer; Neil M Walker; John A Todd; David G Clayton Journal: Nat Genet Date: 2009-12-06 Impact factor: 38.330
Authors: Yun R Li; Jin Li; Sihai D Zhao; Jonathan P Bradfield; Frank D Mentch; S Melkorka Maggadottir; Cuiping Hou; Debra J Abrams; Diana Chang; Feng Gao; Yiran Guo; Zhi Wei; John J Connolly; Christopher J Cardinale; Marina Bakay; Joseph T Glessner; Dong Li; Charlly Kao; Kelly A Thomas; Haijun Qiu; Rosetta M Chiavacci; Cecilia E Kim; Fengxiang Wang; James Snyder; Marylyn D Richie; Berit Flatø; Øystein Førre; Lee A Denson; Susan D Thompson; Mara L Becker; Stephen L Guthery; Anna Latiano; Elena Perez; Elena Resnick; Richard K Russell; David C Wilson; Mark S Silverberg; Vito Annese; Benedicte A Lie; Marilynn Punaro; Marla C Dubinsky; Dimitri S Monos; Caterina Strisciuglio; Annamaria Staiano; Erasmo Miele; Subra Kugathasan; Justine A Ellis; Jane E Munro; Kathleen E Sullivan; Carol A Wise; Helen Chapel; Charlotte Cunningham-Rundles; Struan F A Grant; Jordan S Orange; Patrick M A Sleiman; Edward M Behrens; Anne M Griffiths; Jack Satsangi; Terri H Finkel; Alon Keinan; Eline T Luning Prak; Constantin Polychronakos; Robert N Baldassano; Hongzhe Li; Brendan J Keating; Hakon Hakonarson Journal: Nat Med Date: 2015-08-24 Impact factor: 87.241
Authors: Maria J Redondo; Susan Geyer; Andrea K Steck; Jay Sosenko; Mark Anderson; Peter Antinozzi; Aaron Michels; John Wentworth; Ping Xu; Alberto Pugliese Journal: Diabetes Care Date: 2017-10-12 Impact factor: 19.112
Authors: Karla F Leavens; Juan R Alvarez-Dominguez; Linda T Vo; Holger A Russ; Audrey V Parent Journal: Mol Metab Date: 2022-10-06 Impact factor: 8.568